Oncology Institute Inc
NASDAQ:TOI

Watchlist Manager
Oncology Institute Inc Logo
Oncology Institute Inc
NASDAQ:TOI
Watchlist
Price: 3.435 USD 1.63%
Market Cap: 337.9m USD

Oncology Institute Inc
Total Liabilities & Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Oncology Institute Inc
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Oncology Institute Inc
NASDAQ:TOI
Total Liabilities & Equity
$172.7m
CAGR 3-Years
-5%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Universal Health Services Inc
NYSE:UHS
Total Liabilities & Equity
$15.3B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
5%
Encompass Health Corp
NYSE:EHC
Total Liabilities & Equity
$6.9B
CAGR 3-Years
8%
CAGR 5-Years
1%
CAGR 10-Years
5%
Tenet Healthcare Corp
NYSE:THC
Total Liabilities & Equity
$29.4B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
2%
HCA Healthcare Inc
NYSE:HCA
Total Liabilities & Equity
$59.7B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
6%
Ensign Group Inc
NASDAQ:ENSG
Total Liabilities & Equity
$5.2B
CAGR 3-Years
17%
CAGR 5-Years
16%
CAGR 10-Years
23%
No Stocks Found

Oncology Institute Inc
Glance View

Market Cap
335.2m USD
Industry
Health Care

The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California. The company went IPO on 2020-03-13. The firm manages community-based oncology practices that serve patients at approximately 55 clinic locations across eight markets and four states throughout the United States. The Company’s managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. Through the Innovative Clinical Research Institute (ICRI), the Company also provides and manages clinical trial services and research for the benefit of cancer patients. Its services, such as managing clinical trials, palliative care programs and stem cell transplants, are accessed through academic and tertiary care settings. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.

TOI Intrinsic Value
2.525 USD
Overvaluation 26%
Intrinsic Value
Price

See Also

What is Oncology Institute Inc's Total Liabilities & Equity?
Total Liabilities & Equity
172.7m USD

Based on the financial report for Dec 31, 2024, Oncology Institute Inc's Total Liabilities & Equity amounts to 172.7m USD.

What is Oncology Institute Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
24%

Over the last year, the Total Liabilities & Equity growth was -17%. The average annual Total Liabilities & Equity growth rates for Oncology Institute Inc have been -5% over the past three years , 24% over the past five years .

Back to Top